New Zealand vs Slovenia: New cases tested for RR-/MDR-TB
New Zealand
100.0%
in 2014
Slovenia
100.0%
in 2024
New Zealand rank
1st
Slovenia rank
1st
New cases tested for RR-/MDR-TB over time
- New Zealand
- Slovenia
How they compare
New Zealand currently reports 100.0% against 100.0% in Slovenia, a difference of 0.0%.
Across all 10 years both countries report, Slovenia has been ahead every year.
New Zealand ranks 1st and Slovenia ranks 1st of 192 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 80.5% | 99.8% | 19.3% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, New Zealand or Slovenia?
- New Zealand, at 100.0% against 100.0% in Slovenia as of 2014.
- What is the difference in new cases tested for rr-/mdr-tb between New Zealand and Slovenia?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Slovenia?
- 10 years are reported by both, from 2005 to 2014.
- How do New Zealand and Slovenia rank globally for new cases tested for rr-/mdr-tb?
- New Zealand ranks 1st and Slovenia ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.